Multicenter Validation of a Risk Prediction Model for MDRGNB Infection

Recruiting now

Conditions studied: Infection

In brief

This prospective multicenter validation study aimed to evaluate the predictive performance of a previously developed model for MDRGNB infection in ICU patients.

Key facts

Study ID: NCT07603128
Run by: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
People needed: 1000
Starts: 2026-05-22
Expected to finish: 2028-12-31
Last updated by the study team: 2026-05-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Age ≥18 years;
ICU stay ≥48 hours;
At least one clinical microbiological specimen collected and submitted for testing within 48 hours of ICU admission, with the first submission time designated as the index time;
Core predictive variables of the model extractable from electronic medical records or laboratory information systems.

You may not qualify if…

For patients with multiple ICU admissions, only the first ICU stay was retained;
Missing or indeterminate primary outcome;
Missing key predictive variables that could not be handled according to prespecified rules.

Where it is running

Guangxi Provincial Tumor Hospital — Nanning, China (enrolling)
Shanghai Ruijin Hospital — Shanghai, China (enrolling)
Zhejiang Hospital — Hangzhou, China (enrolling)
Nanjing Drum Tower Hospital — Nanjing, Jiangsu, China (enrolling)
Zhejiang Provincial People's Hospital — Hangzhou, China
Huaian First People's Hospital — Huaian, China
Shaanxi Provincial People's Hospital — Xi'an, China
Zhanjiang Central People's Hospital — Zhanjiang, China
Ankang People's Hospital — Ankang, China
Sinopharm Tongmei General Hospital — Datong, China
First Affiliated Hospital of Gannan Medical University — Ganzhou, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.